References
- Picard N, Yee SW, Woillard JB, Lebranchu Y, Le Meur Y, Giacomini KM,
Marquet P. The role of organic antion-transporting polypeptides and
their common genetic variants in mycophenolic acid pharmacokinetics.
Clin Pharm Ther 2010; 87:100-108.
- Boumar R, Hessenlink DA, van Schaik RHN, Weimar W, van der Heiden I,
de Fijter JW et al. Mycophenolic acid-related diarrhea is not
associated with polymorphisms in SLCO1B nor with ABCB1 in renal
transplant recipients. Pharmacogen Genom 2012; 22:399-407.
- Geng F, Jiao Z, Dao YJ, Qiu XY, Ding JJ, Shi Xj et al. The association
of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the
pharmacokinetics of mycophenolic aid and its phenolic glucuronide
metabolite in Chinese individuals. Clinic Chimica Acta 2012;
423:683-690.
- Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue et al. Influence
of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic
acid pharmacokinetics in Japanese renal transplant recipients. Eur J
Clin Pharmacol 2007; 63:1161-1169.
- van Schaik RHN, van Agteren M, de Fijter JW, Hartmann A, Schmidt J,
Budde K et al. UGT1A9 -275T>A/-2152C>T
polymorphisms correlate with low MPA exposure and acute rejection in
MMF/tacrolimus-treated kidney transplant patients. Clin Pharmacol Ther
2009; 86:319-327.
- Kuypers DR, Naesens M, Vermeire S, Vanrentghem Y. The impact of
uridine diphosphate-glucuronosyltrasferase 1A9 (UGT1A9) gene promoter
region single-nucleotide polymorphisms T-275A and C-2152T on early
mycophenolic acid dose-interval exposure in de novo renal allograft
recipients. Clin Pharmacol Ther 2005; 78:351-361.
- Baldelli S, Merlini S, Perico N, Nicastri A, Cortinovis M et al.
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the
pharmacokinetics of mycophenolic acid in kidney transplantation.
Pharmacogenomics 2007;8:1127-1141.
- Michelon H, Konig J, Durrbach A, Quteineh L, Cerstuyft C, Furlan V et
al. SLCO1B1 genetic polymorphism influences mycophenolic acid
tolerance in renal transplant recipients. Pharmacogenomics 2010;
11:1703-1713.
- Woillard JB, Picard N, Thierry A, Touchard G, Marquet P. Associations
between polymorphisms in target, metabolism or transport proteins of
mycophenenolate sodium and therapeutic or adverse effects in kidney
transplant patients. Pharmacogenet Genomics 2014; 24:256-262.
- Zhao W, Fakhoury M, Deschenes G, Roussey G, Brochard K, Niaudet P et
al. Population pharmacokinetics and pharmacogenetics of mycophenolic
acid following administration of mycophenolate mofetil in de novo
pediatric renal transplant patients. J Clin Pharmacol 2010;
50:1280-1291.
- Pazik J, Oldak M, Dabrowski M, Lewandowski Z, Sitarek E, Podgorska M
et al. Association of udp-glucuronosyltransferase 1A9 (UGT1A9) gene
polymorphism with kindey allograft function. Ann Transplant 2011;
16:69-73.
- Pazik J, Oldak M, Lewandowski Z, Dabrowski M, Podgorska M, Sitarek E
et al. Recipient uridine 5’-diphospho-glucuronosyltransferase UGT1A9
c.98T>C variant determines transplanted kidney filtration
rate. Transplant Proceedings 2014; 46:2678-2682.